MENU
+Compare
IMRX
Stock ticker: NASDAQ
AS OF
Jul 10 closing price
Price
$4.33
Change
-$0.12 (-2.70%)
Capitalization
160.14M

IMRX Immuneering Corp Forecast, Technical & Fundamental Analysis

Immuneering Corp is a biopharmaceutical company... Show more

IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMRX with price predictions
Jul 10, 2025

IMRX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for IMRX moved above the 200-day moving average on July 07, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 18, 2025. You may want to consider a long position or call options on IMRX as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IMRX just turned positive on June 18, 2025. Looking at past instances where IMRX's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMRX advanced for three days, in of 191 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 76 cases where IMRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IMRX broke above its upper Bollinger Band on June 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.724) is normal, around the industry mean (17.368). P/E Ratio (0.000) is within average values for comparable stocks, (59.372). IMRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.445). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (273.506).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IMRX is expected to report earnings to fall 5.68% to -41 cents per share on August 06

Immuneering Corp IMRX Stock Earnings Reports
Q2'25
Est.
$-0.41
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
The last earnings report on May 06 showed earnings per share of -43 cents, beating the estimate of -49 cents. With 907.51K shares outstanding, the current market capitalization sits at 160.14M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMBK14.92N/A
N/A
American Bank, Inc.
AMNC0.04N/A
N/A
Amincor Inc
BRLAF5.19N/A
N/A
British Land Company (The) PLC
SWZNF4100.00N/A
N/A
Schweizerische Nationalbank
VTAGY18.74N/A
N/A
VANTAGE TOWERS AG

IMRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with NUVL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
-2.70%
NUVL - IMRX
35%
Loosely correlated
+0.70%
ORMP - IMRX
29%
Poorly correlated
-2.30%
SRRK - IMRX
29%
Poorly correlated
+3.04%
GOSS - IMRX
29%
Poorly correlated
N/A
VTYX - IMRX
27%
Poorly correlated
+18.33%
More